Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer N Anand, S Murthy, G Amann, M Wernick, LA Porter, IH Cukier, C Collins, ... Nature genetics 31 (3), 301-305, 2002 | 316 | 2002 |
Cyclin B1 and CDK1: nuclear localization and upstream regulators LA Porter, DJ Donoghue PROGRESS IN CELL CYCLE RESEARCH. 5, 335-348, 2003 | 287 | 2003 |
Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2 LA Porter, RW Dellinger, JA Tynan, EA Barnes, M Kong, JL Lenormand, ... The Journal of cell biology 157 (3), 357-366, 2002 | 133 | 2002 |
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression MK Bakht, I Derecichei, Y Li, RM Ferraiuolo, M Dunning, SW Oh, ... Endocrine-related cancer 26 (2), 131-146, 2019 | 117 | 2019 |
Abundance of cyclin B1 regulates γ-radiation–induced apoptosis LA Porter, G Singh, JM Lee Blood, The Journal of the American Society of Hematology 95 (8), 2645-2650, 2000 | 101 | 2000 |
Nuclear localization of cyclin B1 regulates DNA damage–induced apoptosis LA Porter, IH Cukier, JM Lee Blood, The Journal of the American Society of Hematology 101 (5), 1928-1933, 2003 | 75 | 2003 |
Spy1 Interacts with p27Kip1 to Allow G1/S Progression LA Porter, M Kong-Beltran, DJ Donoghue Molecular biology of the cell 14 (9), 3664-3674, 2003 | 73 | 2003 |
A meta‐synthesis of how parents of children with autism describe their experience of advocating for their children during the process of diagnosis K Boshoff, D Gibbs, RL Phillips, L Wiles, L Porter Health & Social Care in the Community 27 (4), e143-e157, 2019 | 72 | 2019 |
Differential expression of glucose transporters and hexokinases in prostate cancer with a neuroendocrine gene signature: a mechanistic perspective for 18F-FDG imaging of PSMA … MK Bakht, JM Lovnicki, J Tubman, KF Stringer, J Chiaramonte, ... Journal of Nuclear Medicine 61 (6), 904-910, 2020 | 66 | 2020 |
Transcriptomics signature from next-generation sequencing data reveals new transcriptomic biomarkers related to prostate cancer A Alkhateeb, I Rezaeian, S Singireddy, D Cavallo-Medved, LA Porter, ... Cancer informatics 18, 1176935119835522, 2019 | 66 | 2019 |
Averting an outbreak of SARS-CoV-2 in a university residence hall through wastewater surveillance R Corchis-Scott, Q Geng, R Seth, R Ray, M Beg, N Biswas, L Charron, ... Microbiology spectrum 9 (2), e00792-21, 2021 | 64 | 2021 |
Human Spy1 promotes survival of mammalian cells following DNA damage EA Barnes, LA Porter, JL Lenormand, RW Dellinger, DJ Donoghue Cancer research 63 (13), 3701-3707, 2003 | 63 | 2003 |
The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis A Golipour, D Myers, T Seagroves, D Murphy, GI Evan, DJ Donoghue, ... Cancer Research 68 (10), 3591-3600, 2008 | 62 | 2008 |
Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27 CW McAndrew, RF Gastwirt, AN Meyer, LA Porter, DJ Donoghue Cell Cycle 6 (15), 1937-1945, 2007 | 52 | 2007 |
Structural basis of divergent cyclin‐dependent kinase activation by Spy1/RINGO proteins DA McGrath, BA Fifield, AH Marceau, S Tripathi, LA Porter, SM Rubin The EMBO journal 36 (15), 2251-2262, 2017 | 50 | 2017 |
The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma D Lubanska, BA Market-Velker, AC deCarvalho, T Mikkelsen, EF da Silva, ... Cancer cell 25 (1), 64-76, 2014 | 50 | 2014 |
Revisiting CDK inhibitors for treatment of glioblastoma multiforme D Lubanska, L Porter Drugs in R&D 17 (2), 255-263, 2017 | 35 | 2017 |
The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer M Al Sorkhy, RM Ferraiuolo, E Jalili, A Malysa, AR Fratiloiu, BF Sloane, ... BMC cancer 12, 1-14, 2012 | 29 | 2012 |
The cyclin-dependent kinase activator, Spy1A, is targeted for degradation by the ubiquitin ligase NEDD4 M Al Sorkhy, R Craig, B Market, R Ard, LA Porter Journal of biological chemistry 284 (5), 2617-2627, 2009 | 28 | 2009 |
α-, β-, and γ-tubulin polymerization in response to DNA damage LA Porter, JM Lee Experimental cell research 270 (2), 151-158, 2001 | 27 | 2001 |